Nature's Miracle Holding Inc. Announces Up to $20 Million Financing with GHS Investment
Nature's Miracle Holding Inc. (OTCQB:NMHI), a vertical farming technology leader, has secured a significant financing agreement with GHS Investments LLC. The agreement allows NMHI to receive up to $20 million in equity financing over 24 months following the registration statement's effective date. As part of the deal, NMHI issued 1,503,759 shares of common stock to GHS. Additionally, GHS invested $250,000 in Series A preferred stock, convertible to common stock at $0.112 per share. The company will file a registration statement with the SEC for these securities and provide further details in an upcoming 8-K filing.
Nature's Miracle Holding Inc. (OTCQB:NMHI), leader nella tecnologia dell'agricoltura verticale, ha ottenuto un importante accordo di finanziamento con GHS Investments LLC. L'accordo consente a NMHI di ricevere fino a 20 milioni di dollari in finanziamenti azionari entro 24 mesi dalla data di efficacia della dichiarazione di registrazione. Nell'ambito dell'accordo, NMHI ha emesso 1.503.759 azioni ordinarie a favore di GHS. Inoltre, GHS ha investito 250.000 dollari in azioni privilegiate di Serie A, convertibili in azioni ordinarie al prezzo di 0,112 dollari per azione. La societ脿 presenter脿 una dichiarazione di registrazione alla SEC per questi titoli e fornir脿 ulteriori dettagli in una prossima comunicazione 8-K.
Nature's Miracle Holding Inc. (OTCQB:NMHI), l铆der en tecnolog铆a de agricultura vertical, ha asegurado un importante acuerdo de financiamiento con GHS Investments LLC. El acuerdo permite a NMHI recibir hasta 20 millones de d贸lares en financiamiento de capital durante 24 meses a partir de la fecha de vigencia de la declaraci贸n de registro. Como parte del acuerdo, NMHI emiti贸 1,503,759 acciones ordinarias a GHS. Adem谩s, GHS invirti贸 250,000 d贸lares en acciones preferentes Serie A, convertibles en acciones ordinarias a 0.112 d贸lares por acci贸n. La empresa presentar谩 una declaraci贸n de registro ante la SEC para estos valores y proporcionar谩 m谩s detalles en una pr贸xima presentaci贸n 8-K.
Nature's Miracle Holding Inc. (OTCQB:NMHI)電� 靾橃 雴嶌梾 旮办垹 攵勳暭鞚� 靹犽憪欤检瀽搿滌劀 GHS Investments LLC鞕 欷戩殧頃� 鞛愱笀 臁半嫭 瓿勳暯鞚� 觳搓舶頄堨姷雼堧嫟. 鞚� 瓿勳暯鞚� 韱淀暣 NMHI電� 霌彪 氇呾劯靹� 氚滍毃鞚茧攵韯� 24臧滌洈 霃欖晥 斓滊寑 2,000毵� 雼煬鞚� 欤检嫕 鞛愱笀鞚� 臁半嫭氚涭潉 靾� 鞛堨姷雼堧嫟. 瓿勳暯鞚� 鞚柬櫂鞙茧 NMHI電� GHS鞐� 1,503,759欤�鞚� 氤错喌欤茧ゼ 氚滍枆頄堨姷雼堧嫟. 霕愴暅 GHS電� 25毵� 雼煬毳� 鞁滊Μ歃� A 鞖办劆欤检棎 韴瀽頄堨溂氅�, 鞚措姅 欤茧嫻 0.112雼煬鞐� 氤错喌欤茧 鞝勴櫂 臧電ロ暕雼堧嫟. 須岇偓電� 鞚� 歃濌秾鞐� 雽頃� SEC鞐� 霌彪 氇呾劯靹滊ゼ 鞝滌稖頃橁碃 瓿� 8-K 氤搓碃靹滌棎靹� 於旉皜 靹鸽秬 靷暛鞚� 鞝滉车頃� 鞓堨爼鞛呺媹雼�.
Nature's Miracle Holding Inc. (OTCQB:NMHI), un leader dans la technologie de l'agriculture verticale, a conclu un accord de financement important avec GHS Investments LLC. Cet accord permet 脿 NMHI de recevoir jusqu'脿 20 millions de dollars de financement par actions sur une p茅riode de 24 mois 脿 compter de la date d'effet de la d茅claration d'enregistrement. Dans le cadre de cet accord, NMHI a 茅mis 1 503 759 actions ordinaires 脿 GHS. De plus, GHS a investi 250 000 dollars dans des actions privil茅gi茅es de s茅rie A, convertibles en actions ordinaires au prix de 0,112 dollar par action. La soci茅t茅 d茅posera une d茅claration d'enregistrement aupr猫s de la SEC pour ces titres et fournira plus de d茅tails dans un prochain d茅p么t 8-K.
Nature's Miracle Holding Inc. (OTCQB:NMHI), ein f眉hrendes Unternehmen im Bereich vertikale Landwirtschaftstechnologie, hat eine bedeutende Finanzierungsvereinbarung mit GHS Investments LLC abgeschlossen. Die Vereinbarung erm枚glicht es NMHI, innerhalb von 24 Monaten nach dem Wirksamkeitsdatum der Registrierungsunterlage bis zu 20 Millionen US-Dollar an Eigenkapitalfinanzierung zu erhalten. Im Rahmen der Vereinbarung hat NMHI 1.503.759 Stammaktien an GHS ausgegeben. Zus盲tzlich hat GHS 250.000 US-Dollar in Vorzugsaktien der Serie A investiert, die zu 0,112 US-Dollar pro Aktie in Stammaktien wandelbar sind. Das Unternehmen wird eine Registrierungsunterlage bei der SEC f眉r diese Wertpapiere einreichen und weitere Details in einer bevorstehenden 8-K Meldung bekanntgeben.
- Secured access to up to $20 million in equity financing over 24 months
- Received immediate $250,000 investment in Series A preferred stock
- Flexibility to draw funds as needed through the equity purchase agreement
- Potential dilution of existing shareholders through new share issuance
- Immediate dilution from issuance of 1,503,759 common shares
- Additional dilution possible from Series A preferred stock conversion at $0.112 per share
About Nature's Miracle Holding Inc.
Nature's Miracle () is a growing agriculture technology company providing products and services to growers in the Controlled Environment Agriculture ("CEA") industry in the
Forward-Looking Statements
The information in this press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast," "intends," "may," "will," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: the intended use of proceeds from the offering; successful launch and implementation of Nature's Miracle's joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in Nature's Miracle's strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; Nature's Miracle's ability to develop and launch new products and services; Nature's Miracle's ability to successfully and efficiently integrate future expansion plans and opportunities; Nature's Miracle's ability to grow its business in a cost-effective manner; Nature's Miracle's product development timeline and estimated research and development costs; the implementation, market acceptance and success of Nature's Miracle's business model; developments and projections relating to Nature's Miracle's competitors and industry; and Nature's Miracle's approach and goals with respect to technology.
These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company's shares on the OTC; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which Nature's Miracle's operates; the risk that Nature's Miracle's and its current and future collaborators are unable to successfully develop and commercialize Nature's Miracle's products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that Nature's Miracle's is unable to secure or protect its intellectual property; the possibility that Nature's Miracle's may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in Nature's Miracle's filings from time to time with the SEC.
听
听
View original content:
SOURCE Nature's Miracle Holding Inc.